Catalyst Wire Dossier Catalyst Wire Dossier

Activated T Lymphocytes (ATL)

Activated T Lymphocytes · Lukas Biomedical Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Activated T Lymphocytes (ATL), covering 2025-03-06 to 2025-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma [Phase 2]

See pricing